PGEN vs QURE Stock Comparison

PGEN currently leads QURE in this stock comparison, with AIQ scores of 55 vs 39. The clearest difference is value.

Market data as of Nov 15, 2026 market close· AIQ score gap 16 points
PGEN
Healthcare
vs
QURE
Healthcare
PGEN
Precigen, Inc.
Leads
Price
$4.54
Day move
-2.58%
AIQ Score
55/100
Best edge
Value
Sector
Healthcare
QURE
uniQure N.V.
Price
$23.81
Day move
-3.33%
AIQ Score
39/100
Best edge
Balanced
Sector
Healthcare

What is the main difference between PGEN and QURE?

PGEN leads the current stock comparison as Precigen, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Precigen, Inc. vs uniQure N.V.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

PGEN leads

PGEN leads by 16 AIQ points, primarily on Value and Quality.

Competitive: 4 of 6 evidence groups support PGEN, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Stable
PGEN

Precigen, Inc.

Leads
AIQ Score
55/100
AIQ Edge Score
5/10
QURE

uniQure N.V.

AIQ Score
39/100
AIQ Edge Score
2/10

The Algovestiq AIQ Score currently favors PGEN over QURE, 55 versus 39 as of Nov 15, 2026. PGEN's advantage is driven primarily by stronger value and quality. PGEN also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor PGEN today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. PGEN lead: Stable — the AIQ differential has held near 16 points over 30 sessions.

Compare Precigen, Inc. and uniQure N.V. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

PGEN
+21.1%
QURE
-20.4%

Price return comparison

Growth of $10,000, price only

PGEN $12,107 · QURE $7,955

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare PGEN and QURE against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

PGEN advantage
0
QURE advantage
  • Value63 vs 38
    PGEN +25
  • Quality60 vs 42
    PGEN +18
  • Momentum55 vs 41
    PGEN +14
  • Risk Resilience31 vs 31
    Even

4 of 6 evidence groups favor PGEN. PGEN’s edge is concentrated in value and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

PGEN+1 AIQ

No factor moved materially.

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon
QURE0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

New signals

  • Death Cross Active — bearish, trend, long horizon (0.48%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.71x)

PGEN's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — PGEN and QURE both carry a full feed there.

The central trade-off

PGEN (Precigen, Inc.): the stronger current systematic profile, led by value and quality.

QURE (uniQure N.V.): the counter-case, on technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

PGEN

PGEN on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

PGEN

PGEN on combined revenue and EPS growth.

Value

PGEN

PGEN on the peer-relative Value factor, by 25 points.

Momentum

PGEN

PGEN on the Momentum factor, by 14 points.

Lower downside

QURE

QURE carries the lower 1-month annualized volatility.

Analyst upside

PGEN

PGEN on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasurePGENQURENote
Implied upside to target+164.3%+110.7%PGEN has more room
Target dispersion0%+93.7%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering413Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor PGEN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScorePGEN55 vs 39
FundamentalsPGENrevenue growth 34.9% vs -11%; EPS growth 66.7% vs 27.9%; TTM ROE 42.7% vs -20.8%; gross margin 91% vs 29.3%; operating margin 21.4% vs -10.2%
ValuationPGENValue 63 vs 38
TechnicalsQUREPrice vs 50-day -32.6% vs -19.3%; vs 200-day -14% vs -19.7%
Risk ResilienceEvenRisk Resilience 31 vs 31
Analyst expectationsPGENTarget upside 164.3% vs 110.7%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PGEN and QURE and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 16 points. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PGEN.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

PGEN lead: Stable — the AIQ differential has held near 16 points over 30 sessions.

May 27PGEN leads above the line · QURE leads belowNov 13
Today
PGEN +16
55 vs 39
7 sessions ago
PGEN +22
62 vs 40
30 sessions ago
PGEN +17
61 vs 44
90 sessions ago
PGEN +2
58 vs 56

The lead changed hands once in this window, most recently on Aug 4 when PGEN moved ahead of QURE.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

PGENConflicted

1 bullish / 2 bearish / 2 neutral, conflicted

Only PGEN

  • Golden Cross Active — bullish, trend, long horizon (27.69%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon
QURE

0 bullish / 4 bearish / 1 neutral

Only QURE

  • Death Cross Active — bearish, trend, long horizon (0.48%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.71x)

Both carry 2 more signals that do not separate them: ATR Expansion - Breakout Mode, Beta Spike Warning.

PGEN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

PGENDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.58%, AIQ +1 points).

QURENo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -3.33%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1QURE closes the Value gap — currently 25 points behind, the largest single contributor to PGEN's edge.
  2. 2QURE's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3PGEN's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

PGEN leads on balance
MetricPGENQURE
Revenue growth (YoY)34.9%-11%
EPS growth (YoY)66.7%27.9%
Gross margin91%29.3%
Operating margin21.4%-10.2%
Return on equity (TTM)42.7%-20.8%
Debt to equity1.180.21

Performance

PGEN leads 4 of 6 windows
MetricPGENQURE
1 week (5 sessions)1.6%9.7%
1 month (20 sessions)-28.9%9.3%
3 months (63 sessions)-30.7%-50.4%
6 months (126 sessions)2.7%-12%
Year to date8.6%-0.5%
1 year (252 sessions)12.9%-20.9%

Technicals

QURE has the stronger structure
MetricPGENQURE
RSI (14)34.245.7
ADX (14)28.825.3
Price vs 50-day-32.6%-19.3%
Price vs 200-day-14%-19.7%
Volatility (1M, annualized)127%78.5%

Risk

Split
MetricPGENQURE
Beta1.620.68
Sharpe ratio0.570.39
Sortino ratio0.870.68
Max drawdown-50.7%-70.2%
Current drawdown-47%-53.4%
Annualized volatility85.4%132.3%
Value at risk (95%)-7.2%-7.7%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, PGEN or QURE?

On the Algovestiq AIQ Score, PGEN is the stronger of the two as of Nov 15, 2026, scoring 55 against QURE's 39. The edge comes from value and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is PGEN or QURE the better buy right now?

PGEN carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor PGEN over QURE?

The composite weights Quality, Value, Momentum and Risk Resilience. PGEN leads Value by 25 points; PGEN leads Quality by 18 points; PGEN leads Momentum by 14 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, PGEN or QURE?

Analyst price targets imply +164.3% upside for PGEN and +110.7% for QURE, so the Street currently favors PGEN. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, PGEN or QURE?

PGEN is the better-valued of the two on the peer-relative Value factor. PGEN on the peer-relative Value factor, by 25 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, PGEN or QURE?

PGEN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, PGEN or QURE?

PGEN on the Momentum factor, by 14 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, PGEN or QURE?

QURE is the more resilient of the two, so the other name carries the higher downside risk. QURE carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is PGEN more profitable than QURE?

PGEN leads on the comparable margin measures — gross margin 91% vs 29.3%; operating margin 21.4% vs -10.2%; ttm roe 42.7% vs -20.8%.

Is PGEN's lead over QURE getting stronger or weaker?

PGEN lead: Stable — the AIQ differential has held near 16 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-08-04, when PGEN moved ahead of QURE.

What would change the PGEN vs QURE verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: QURE closes the Value gap — currently 25 points behind, the largest single contributor to PGEN's edge; QURE's Death Cross Active resolves — a bearish trend rule currently active against it; PGEN's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about PGEN and QURE?

PGEN: 1 bullish / 2 bearish / 2 neutral, conflicted. QURE: 0 bullish / 4 bearish / 1 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PGEN is Golden Cross Active (bullish, long horizon). On QURE it is Death Cross Active (bearish, long horizon).

Compare PGEN and QURE with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.